Toxoplasma encephalitis after initiation of HAART

AIDS Reader

Volumn 11, Issue 12, 2001, Pages 608-616

  Tsambiras, P E ^a   Larkin, J A ^a   Houston, S H ^a  

^a Florida Medical Clinic   (United States)

Author keywords

Encephalitis; HAART; HIV AIDS; Immune restoration disease; Toxoplasma gondii

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; LAMIVUDINE; NELFINAVIR; PHENYTOIN; PYRIMETHAMINE SULFADIAZINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; ENCEPHALITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOASSAY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PHYSICAL EXAMINATION; TOXOPLASMA GONDII; VIRUS LOAD; AIDS RELATED COMPLEX; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE SYSTEM; IMMUNOLOGY; MIDDLE AGED; SYNDROME; TOXOPLASMOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ENCEPHALITIS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE SYSTEM; MIDDLE AGED; SYNDROME; TOXOPLASMOSIS, CEREBRAL;

EID: 0035673106     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Improved survival among HIV-infected patients after initiation of tripledrug antiretroviral regimens
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy
4. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy
5. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors
6. Immunorestitution disease involving the innate and adaptive response
7. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
8. Immune restoration disease in HIV-infected patients on HAART
9. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
10. Paradoxical reactions in HIV and pulmonary TB
11. Opportunistic infections occurring during highly active antiretroviral treatment
12. HAART-associated lymphadenopathy
13. Focal lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease
14. Immunorestitution disease in relation to infection with Mycobacterium avium complex and to leprosy
15. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy
16. Opportunistic infections shortly after beginning highly active antiretroviral therapy